Srdanović, I.; Stefanović, M.; Milovančev, A.; Vulin, A.; Pantić, T.; Dabović, D.; Tadić, S.; Ilić, A.; Stojšić Milosavljević, A.; Bjelobrk, M.;
et al. Relevance of the TAS’/PASP Ratio as a Predictor of Outcomes in Patients with Heart Failure with a Reduced Ejection Fraction. Life 2024, 14, 863.
https://doi.org/10.3390/life14070863
AMA Style
Srdanović I, Stefanović M, Milovančev A, Vulin A, Pantić T, Dabović D, Tadić S, Ilić A, Stojšić Milosavljević A, Bjelobrk M,
et al. Relevance of the TAS’/PASP Ratio as a Predictor of Outcomes in Patients with Heart Failure with a Reduced Ejection Fraction. Life. 2024; 14(7):863.
https://doi.org/10.3390/life14070863
Chicago/Turabian Style
Srdanović, Ilija, Maja Stefanović, Aleksandra Milovančev, Aleksandra Vulin, Teodora Pantić, Dragana Dabović, Snežana Tadić, Aleksandra Ilić, Anastazija Stojšić Milosavljević, Marija Bjelobrk,
and et al. 2024. "Relevance of the TAS’/PASP Ratio as a Predictor of Outcomes in Patients with Heart Failure with a Reduced Ejection Fraction" Life 14, no. 7: 863.
https://doi.org/10.3390/life14070863
APA Style
Srdanović, I., Stefanović, M., Milovančev, A., Vulin, A., Pantić, T., Dabović, D., Tadić, S., Ilić, A., Stojšić Milosavljević, A., Bjelobrk, M., Miljković, T., & Velicki, L.
(2024). Relevance of the TAS’/PASP Ratio as a Predictor of Outcomes in Patients with Heart Failure with a Reduced Ejection Fraction. Life, 14(7), 863.
https://doi.org/10.3390/life14070863
